MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 94 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,916,000 | -35.8% | 469,494 | -0.2% | 0.00% | -50.0% |
| Q3 2016 | $2,986,000 | +17.4% | 470,238 | -0.3% | 0.00% | +33.3% |
| Q2 2016 | $2,543,000 | -24.3% | 471,710 | +17.5% | 0.00% | -25.0% |
| Q1 2016 | $3,361,000 | +12.3% | 401,507 | +6.0% | 0.00% | 0.0% |
| Q4 2015 | $2,992,000 | -5.4% | 378,686 | +1.9% | 0.00% | 0.0% |
| Q3 2015 | $3,163,000 | -31.9% | 371,632 | -1.1% | 0.00% | -33.3% |
| Q2 2015 | $4,646,000 | +42.8% | 375,750 | +37.2% | 0.01% | +50.0% |
| Q1 2015 | $3,253,000 | +6.9% | 273,816 | +1.6% | 0.00% | 0.0% |
| Q4 2014 | $3,044,000 | +27.6% | 269,375 | -0.9% | 0.00% | +33.3% |
| Q3 2014 | $2,386,000 | +20.6% | 271,772 | +0.1% | 0.00% | 0.0% |
| Q2 2014 | $1,979,000 | +46.4% | 271,406 | +1.2% | 0.00% | +50.0% |
| Q1 2014 | $1,352,000 | -5.1% | 268,251 | +0.4% | 0.00% | 0.0% |
| Q4 2013 | $1,425,000 | +38.2% | 267,224 | -1.8% | 0.00% | 0.0% |
| Q3 2013 | $1,031,000 | -35.2% | 271,998 | +15.1% | 0.00% | -33.3% |
| Q2 2013 | $1,592,000 | – | 236,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
| Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
| Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
| INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
| GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
| Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
| Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |